HOME › DRUGS › RIFAXIMIN
ACTIVE SUBSTANCE / INN

RIFAXIMIN

Brand name(s): RIFAXIMIN, XIFAXAN
FDA LISTED
PRESCRIPTION
NONE (TENTATIVE APPROVAL)
NDA021361
ANDA214370
ACTIVE SUBSTANCE
Rifaximin
REGULATORS
FDA
SPONSORS / MAH
SALIX PHARMS, NORWICH
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
XIFAXANNDA021361SALIX PHARMSPrescription
RIFAXIMINANDA214370NORWICHNone (Tentative Approval)

FULL INTELLIGENCE ON RIFAXIMIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →